BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38741077)

  • 1. Neuropsychological profile associated with KAT6A syndrome: Emergent genotype-phenotype trends.
    Ng R; Kalinousky AJ; Harris J
    Orphanet J Rare Dis; 2024 May; 19(1):196. PubMed ID: 38741077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Speech and language development and genotype-phenotype correlation in 49 individuals with KAT6A syndrome.
    St John M; Amor DJ; Morgan AT
    Am J Med Genet A; 2022 Dec; 188(12):3389-3400. PubMed ID: 35892268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KAT6A Syndrome: genotype-phenotype correlation in 76 patients with pathogenic KAT6A variants.
    Kennedy J; Goudie D; Blair E; Chandler K; Joss S; McKay V; Green A; Armstrong R; Lees M; Kamien B; Hopper B; Tan TY; Yap P; Stark Z; Okamoto N; Miyake N; Matsumoto N; Macnamara E; Murphy JL; McCormick E; Hakonarson H; Falk MJ; Li D; Blackburn P; Klee E; Babovic-Vuksanovic D; Schelley S; Hudgins L; Kant S; Isidor B; Cogne B; Bradbury K; Williams M; Patel C; Heussler H; Duff-Farrier C; Lakeman P; Scurr I; Kini U; Elting M; Reijnders M; Schuurs-Hoeijmakers J; Wafik M; Blomhoff A; Ruivenkamp CAL; Nibbeling E; Dingemans AJM; Douine ED; Nelson SF; ; Hempel M; Bierhals T; Lessel D; Johannsen J; Arboleda VA; Newbury-Ecob R
    Genet Med; 2019 Apr; 21(4):850-860. PubMed ID: 30245513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal hepatic calcification in severe KAT6A (Arboleda-Tham) syndrome.
    Di Caprio A; Rossi C; Bertucci E; Bedetti L; Bertoncelli N; Miselli F; Corso L; Bondi C; Iughetti L; Berardi A; Lugli L
    Eur J Med Genet; 2024 Feb; 67():104906. PubMed ID: 38143025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of Arboleda-Tham syndrome by whole-exome sequencing in an Asian girl with severe developmental delay.
    Wang Q; Zhang Y; Li L; Yang N
    Mol Genet Genomic Med; 2024 May; 12(5):e2420. PubMed ID: 38773911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Speech-language profiles in the context of cognitive and adaptive functioning in SATB2-associated syndrome.
    Snijders Blok L; Goosen YM; van Haaften L; van Hulst K; Fisher SE; Brunner HG; Egger JIM; Kleefstra T
    Genes Brain Behav; 2021 Sep; 20(7):e12761. PubMed ID: 34241948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dominant mutations in KAT6A cause intellectual disability with recognizable syndromic features.
    Tham E; Lindstrand A; Santani A; Malmgren H; Nesbitt A; Dubbs HA; Zackai EH; Parker MJ; Millan F; Rosenbaum K; Wilson GN; Nordgren A
    Am J Hum Genet; 2015 Mar; 96(3):507-13. PubMed ID: 25728777
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Singh M; Spendlove S; Wei A; Bondhus L; Nava A; de L Vitorino FN; Amano S; Lee J; Echeverria G; Gomez D; Garcia BA; Arboleda VA
    bioRxiv; 2023 Aug; ():. PubMed ID: 37577627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The autism spectrum phenotype in ADNP syndrome.
    Arnett AB; Rhoads CL; Hoekzema K; Turner TN; Gerdts J; Wallace AS; Bedrosian-Sermone S; Eichler EE; Bernier RA
    Autism Res; 2018 Sep; 11(9):1300-1310. PubMed ID: 30107084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KAT6A mutations in Arboleda-Tham syndrome drive epigenetic regulation of posterior HOXC cluster.
    Singh M; Spendlove SJ; Wei A; Bondhus LM; Nava AA; de L Vitorino FN; Amano S; Lee J; Echeverria G; Gomez D; Garcia BA; Arboleda VA
    Hum Genet; 2023 Dec; 142(12):1705-1720. PubMed ID: 37861717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective investigation of FOXP1 syndrome.
    Siper PM; De Rubeis S; Trelles MDP; Durkin A; Di Marino D; Muratet F; Frank Y; Lozano R; Eichler EE; Kelly M; Beighley J; Gerdts J; Wallace AS; Mefford HC; Bernier RA; Kolevzon A; Buxbaum JD
    Mol Autism; 2017; 8():57. PubMed ID: 29090079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanding the phenotype of Kleefstra syndrome: speech, language and cognition in 103 individuals.
    Morison LD; Kennis MGP; Rots D; Bouman A; Kummeling J; Palmer E; Vogel AP; Liegeois F; Brignell A; Srivastava S; Frazier Z; Milnes D; Goel H; Amor DJ; Scheffer IE; Kleefstra T; Morgan AT
    J Med Genet; 2024 May; 61(6):578-585. PubMed ID: 38290825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole exome sequencing reveals de novo pathogenic variants in KAT6A as a cause of a neurodevelopmental disorder.
    Millan F; Cho MT; Retterer K; Monaghan KG; Bai R; Vitazka P; Everman DB; Smith B; Angle B; Roberts V; Immken L; Nagakura H; DiFazio M; Sherr E; Haverfield E; Friedman B; Telegrafi A; Juusola J; Chung WK; Bale S
    Am J Med Genet A; 2016 Jul; 170(7):1791-8. PubMed ID: 27133397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive and academic outcomes in long-term survivors of infantile-onset Pompe disease: A longitudinal follow-up.
    Spiridigliozzi GA; Keeling LA; Stefanescu M; Li C; Austin S; Kishnani PS
    Mol Genet Metab; 2017 Jun; 121(2):127-137. PubMed ID: 28495044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What Have We Learned from Patients Who Have Arboleda-Tham Syndrome Due to a De Novo
    Bukvic N; Chetta M; Bagnulo R; Leotta V; Pantaleo A; Palumbo O; Palumbo P; Oro M; Rivieccio M; Laforgia N; De Rinaldis M; Rosati A; Kerkhof J; Sadikovic B; Resta N
    Genes (Basel); 2023 Jan; 14(1):. PubMed ID: 36672906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sleep, Behavior, and Adaptive Function in KAT6A Syndrome.
    Smith C; Harris J
    Brain Sci; 2021 Jul; 11(8):. PubMed ID: 34439586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurobehavioral and developmental profiles: genotype-phenotype correlations in individuals with Cornelia de Lange syndrome.
    Ng R; O'Connor J; Summa D; Kline AD
    Orphanet J Rare Dis; 2024 Mar; 19(1):111. PubMed ID: 38462617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pantothenate and L-Carnitine Supplementation Improves Pathological Alterations in Cellular Models of KAT6A Syndrome.
    Munuera-Cabeza M; Álvarez-Córdoba M; Suárez-Rivero JM; Povea-Cabello S; Villalón-García I; Talaverón-Rey M; Suárez-Carrillo A; Reche-López D; Cilleros-Holgado P; Piñero-Pérez R; Sánchez-Alcázar JA
    Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epilepsy in KAT6A syndrome: Description of two individuals and revision of the literature.
    Troisi S; Maitz S; Severino M; Spano A; Cappuccio G; Brunetti-Pierri N; Torella A; Nigro V; Tudp ; Bilo L; Coppola A
    Eur J Med Genet; 2022 Jan; 65(1):104380. PubMed ID: 34748993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical spectrum of a nonsense mutation in
    Wang D; He J; Li X; Yan S; Pan L; Wang T; Zhou L; Liu J; Peng X
    J Int Med Res; 2022 Dec; 50(12):3000605221140304. PubMed ID: 36573038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.